- Home
- TRMD vs SUPN Comparison
TRMD vs SUPN Comparison
Compare TRMD & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRMD
- SUPN
- Stock Information
- Founded
- TRMD 1889
- SUPN 2005
- Country
- TRMD United Kingdom
- SUPN United States
- Employees
- TRMD N/A
- SUPN N/A
- Industry
- TRMD Marine Transportation
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- TRMD Consumer Discretionary
- SUPN Health Care
- Exchange
- TRMD Nasdaq
- SUPN Nasdaq
- Market Cap
- TRMD 1.8B
- SUPN 1.9B
- IPO Year
- TRMD N/A
- SUPN 2012
- Fundamental
- Price
- TRMD $18.90
- SUPN $33.56
- Analyst Decision
- TRMD Buy
- SUPN Hold
- Analyst Count
- TRMD 1
- SUPN 2
- Target Price
- TRMD $23.00
- SUPN $36.00
- AVG Volume (30 Days)
- TRMD 653.8K
- SUPN 681.6K
- Earning Date
- TRMD 08-14-2025
- SUPN 08-05-2025
- Dividend Yield
- TRMD 21.15%
- SUPN N/A
- EPS Growth
- TRMD N/A
- SUPN N/A
- EPS
- TRMD 4.74
- SUPN 1.11
- Revenue
- TRMD $1,444,200,000.00
- SUPN $667,997,000.00
- Revenue This Year
- TRMD N/A
- SUPN N/A
- Revenue Next Year
- TRMD N/A
- SUPN $15.74
- P/E Ratio
- TRMD $3.99
- SUPN $30.78
- Revenue Growth
- TRMD N/A
- SUPN 11.82
- 52 Week Low
- TRMD $13.60
- SUPN $27.05
- 52 Week High
- TRMD $39.04
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- TRMD 57.83
- SUPN 57.11
- Support Level
- TRMD $18.51
- SUPN $32.94
- Resistance Level
- TRMD $19.70
- SUPN $34.21
- Average True Range (ATR)
- TRMD 0.41
- SUPN 1.06
- MACD
- TRMD 0.14
- SUPN 0.04
- Stochastic Oscillator
- TRMD 66.38
- SUPN 56.90
About TRMD TORM plc
TORM PLC operates as a shipping company. The company owns and operates product tankers. It is engaged in the transportation of refined oil products The company transports clean petroleum products including gasoline, jet fuel, naphtha, and diesel oil, as well as other clean products. Its segments include the Tanker segment, and Marine Engineering segment. The company derives maximum revenue from Tanker segment.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.